9,10-dimethyl-1,2-benzanthracene and 1-hydroxyvitamin d5

9,10-dimethyl-1,2-benzanthracene has been researched along with 1-hydroxyvitamin d5 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Constantinou, A; Guo, L; Lazzaro, G; Mehta, RG; Mehta, RR; Moriarty, RM; Penmasta, R	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and 1-hydroxyvitamin d5

Article	Year
Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. Journal of the National Cancer Institute, 1997, Feb-05, Volume: 89, Issue:3 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Calcitriol; Calcium; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Hydroxycholecalciferols; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Transforming Growth Factor beta; Vitamin D	1997

Article

Year

Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.

Journal of the National Cancer Institute, 1997, Feb-05, Volume: 89, Issue:3

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Calcitriol; Calcium; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Hydroxycholecalciferols; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Transforming Growth Factor beta; Vitamin D

1997